loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Epoprostenol

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Epoprostenol

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,173,428Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mylan's Generic Epoprostenol Sodium Receives Approval in US
    Mylan's Generic Epoprostenol Sodium Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213913

    FDA
    12 Jun 2024
    Share Share
    Teva's troubled plant seen to create injectable drug shortages
    Teva's troubled plant seen to create injectable drug shortages

    24 May 2022

    // Joseph Keenan FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

    Joseph Keenan FIERCEPHARMA
    24 May 2022
    Share Share
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    25 Aug 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share
    Enforcement Report - Week of March 3, 2021
    Enforcement Report - Week of March 3, 2021

    03 Mar 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf

    FDA
    03 Mar 2021
    Share Share
    Sun Pharm`s Generic Epoprostenol Sodium Receives Tentative Approval In US
    Sun Pharm`s Generic Epoprostenol Sodium Receives Tentative Approval In US

    21 Jan 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210473

    FDA
    21 Jan 2021
    Share Share
    J&J unit to pay $360 million to U.S. to resolve charity kickback probe
    J&J unit to pay $360 million to U.S. to resolve charity kickback probe

    07 Dec 2018

    // Nate Raymond REUTERS

    https://www.reuters.com/article/us-johnson-johnson-settlement/jj-unit-to-pay-360-million-to-u-s-to-resolve-charity-kickback-probe-idUSKBN1O51XB

    Nate Raymond REUTERS
    07 Dec 2018
    Share Share